{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-001764","form_type":"8-K","ticker":"ESPR","cik":"0001434868","company_name":"Esperion Therapeutics, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.075553+00:00","generated_at":"2026-05-16T10:49:56.497858+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Esperion reports preliminary 2025 revenue up 20-23%, U.S. sales up 35-38%; provides 2026 OpEx guidance","bullets":["Preliminary 2025 U.S. net product sales $156-160M, up 35-38% YoY; total revenue $400-408M, up 20-23%.","Cash and equivalents ~$168M at year-end 2025; completed $75M capital raise in 2025.","2026 operating expenses expected $210-245M, including $15M non-cash stock compensation.","Patent settlements with four ANDA filers restrict generic entry until April 2040; no remaining patent challenges.","R&D pipeline: nominated ESP-2001 (ACLY inhibitor) for primary sclerosing cholangitis; blockbuster potential >$1B."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-001764","json":"https://secwatch.observer/filing/0001628280-26-001764.json","markdown":"https://secwatch.observer/filing/0001628280-26-001764.md","text":"https://secwatch.observer/filing/0001628280-26-001764.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026001764/0001628280-26-001764-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434868/000162828026001764/espr-20260111.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:49:56.497858+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}